ArticleThe pharmacogenomics journal2020

Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data.

Nita A Limdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.